Cancer Channel
Related Channels

Genetic Test Prior to Starting Irinotecan

Your healthcare provider may recommend that you take a genetic test, or DNA test, prior to starting treatment with irinotecan (Camptosar®). This test can help determine whether you have an increased risk for developing certain side effects with the medication.
This test will look to see if you have a variation in a gene known as UGT1A1. If you do have this gene variation, you may have an increased risk for developing low white blood cell counts during treatment. To help minimize this risk, your healthcare provider will likely start you on a lower initial dosage of irinotecan.
(Click Precautions and Warnings With Irinotecan for more details, including other safety precautions to be aware of before receiving this drug.)
5 Easy Tips to Manage Visitors During Cancer Treatment
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.